Myriad Genetics provides 2025 preliminary results and 2026 guidance

Go back to Myriad Genetics provides 2025 preliminary results and 2026 guidance
Myriad Genetics, Inc. (NASDAQ: MYGN) Delayed: 3.42 +0.06 (1.79%)
Previous Close $3.36    52 Week High $45.34 
Open $3.37    52 Week Low $15.92 
Day High $3.43    P/E 1.47 
Day Low $3.20    EPS $2.33 
Volume 2,552,914